GalNAc
GalNAc-L96 analog
Quick view. We supply GalNAc-L96 analog as a triantennary GalNAc ligand intermediate for ASGPR-targeted oligonucleotide delivery programs. Catalog identity: CAS 1159408-72-6 for this L96 analog. CAS 1159408-72-6. Catalog target purity: Specification on request.
Structure and identity
The structure drawing for this item is being finalized. Use the CAS number and machine-readable identifiers below to confirm the requested protecting groups, stereochemistry, salt or counterion and hydration state before ordering.
CAS, molecular formula, SMILES or InChI data are shown below when available.
We withhold a drawing when a related compound, alternate salt or incompletely specified stereoisomer could be mistaken for the requested material.
Agreed identity and purity criteria are documented in the quotation, specification and lot-specific data package.
Product profile
GalNAc-L96 analog is classified as galnac ligand, linker or conjugation intermediate (Formula C117H175N11O42; molecular weight 2407.69).
GalNAc-L96 analog is an intermediate in the synthesis of the asialoglycoprotein receptor (ASGPR) ligand GalNAc-L96.
For GalNAc-L96 analog, reported solubility: DMSO: Soluble: =10 mg/ml Ethanol: Soluble: =10 mg/ml.
Names and search terms
Useful catalog search terms
- CAS 1159408-72-6
- GalNAc ligand, linker or conjugation intermediate
- GalNAc ligand motif
- GalNAc
Physicochemical data
| Key chemistry motifs | GalNAc ligand motif |
|---|---|
| Boiling point | 1849.6±65.0 °C(Predicted) |
| Density | 1.29±0.1 g/cm3(Predicted) |
| pKa | 13.13±0.70(Predicted) |
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.
Additional application examples
- GalNAc-L96 analog can be evaluated in ligand, linker and conjugation-route development for oligonucleotide delivery research.
- Typical studies compare linker length, valency, attachment chemistry, purification strategy and analytical identity.
- The material may also support conjugate-reference or impurity-standard preparation.
Product-specific evaluation notes
Potential advantages
- A defined GalNAc intermediate helps decouple ligand-linker optimization from sequence optimization.
Method limitations
- In-vitro affinity and in-vivo delivery behavior may diverge; valency, linker length and conjugation site need empirical confirmation.
These points describe GalNAc-L96 analog or its named chemical feature. Broader product-family guidance is maintained on the category page.
Related products
(6R)-FR054
GalNAc · CAS: 10378-06-0
BX-GALN-0002AdemA-GalNAc Phosphoramidite
GalNAc · CAS: 1953147-02-8
BX-GALN-0003AdemC-GalNAc Phosphoramidite
GalNAc · CAS: N/A
BX-GALN-0004GalNAc PEG Cluster Phosphoramidite
GalNAc · CAS: N/A
BX-GALN-0005GalNAc-L96 Linker-Acid
GalNAc · CAS: 1426159-34-3
BX-GALN-0006GalNAc-L96 Linker-Azide
GalNAc · CAS: 2135330-72-0
Frequently asked questions
Can the package size for GalNAc-L96 analog be customized?
Yes. Share the initial quantity, expected future scale, delivery timeline and packaging preference for review.
What information should be included in a quote request?
Quote catalog number BX-GALN-0030 and CAS 1159408-72-6, the intended research workflow, required quantity and any additional HPLC, MS or NMR documentation needed.
Product-family literature
The publications below provide peer-reviewed context for the GalNAc product family and its named chemistry.